Results 11 to 20 of about 67,053 (243)

Histologically confirmed upper gastrointestinal Crohn’s disease: is it rare or are we just not searching hard enough? [PDF]

open access: yesIntestinal Research, 2020
Background/Aims Crohn’s disease (CD) may involve the upper parts of the gastrointestinal (GI) tract including the esophagus, stomach, and duodenum. Clinical features of upper GI CD (UGICD) are not well characterized in the Gulf region. We therefore aimed
Omar Ibrahim Saadah   +11 more
doaj   +1 more source

Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis. [PDF]

open access: yesPLoS ONE, 2015
The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of pill-induced esophagitis vs.
Ji Won Kim   +7 more
doaj   +1 more source

Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. OBJECTIVE: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of
Julio Ponce   +5 more
doaj   +1 more source

Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study

open access: yesInflammatory Intestinal Diseases, 2021
Introduction: Faecal calprotectin (FC) is commonly used as a diagnostic tool for patients with gastrointestinal (GI) symptoms. However, there is uncertainty in daily clinical practice how to interpret an elevated FC in patients with a normal colonoscopy.
Henrik Hovstadius   +2 more
doaj   +1 more source

Atypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis

open access: yesCase Reports in Gastroenterology, 2021
Esophagitis is described as an inflammation of the esophagus and can result from multiple etiologies. Esophageal squamous cell carcinoma (ESCC), presenting as diffuse esophagitis in the absence of a mass or lesion, is rare. We present a case of a 61-year-
Hafsa Abbas   +4 more
doaj   +1 more source

Endocytoscopic Observation of Esophageal Lesions: Our Own Experience and a Review of the Literature

open access: yesDiagnostics, 2022
This review outlines the process of the development of the endocytoscope (EC) with reference to previously reported studies including our own. The EC is an ultra-high-magnification endoscope capable of imaging at the cellular level.
Youichi Kumagai   +10 more
doaj   +1 more source

Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

open access: yesМедицинский совет, 2022
Introduction. Gastroesophageal reflux disease (GERD) is extremely common in the structure of gastroenterological diseases. Aim. To conduct a prospective observational post-marketing study of rabeprazole (Razo®) 20 mg taking once daily in patients with ...
V. V. Tsukanov   +6 more
doaj   +1 more source

First Therapeutic Approval for Eosinophilic Esophagitis

open access: yesGastroenterology Insights, 2022
Eosinophilic esophagitis (EE) is a chronic, immune-mediated or antigen-mediated esophageal disease. Treatment for patients with EE can be challenging with no previously approved medications.
Rami A. Al-Horani, Raquel Chiles
doaj   +1 more source

Amoxycillin-Clavulanic Acid-Induced Esophageal Ulcer: An Unusual Cause

open access: yesCase Reports in Gastroenterology, 2020
Pill-induced esophagitis or esophageal ulcers are considered when patients have retrosternal chest pain or odynophagia following the ingestion of suspicious medications. Various drugs have been reported to induce esophageal ulcers.
Apichat Kaewdech   +2 more
doaj   +1 more source

Steroids in pediatric eosinophilic esophagitis [PDF]

open access: yes, 2014
Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids.
Contreras, Emily M., Gupta, Sandeep K.
core   +1 more source

Home - About - Disclaimer - Privacy